scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.WATRES.2016.02.022 |
P698 | PubMed publication ID | 26938496 |
P50 | author | Maite Pijuan | Q47188916 |
Gianluigi Buttiglieri | Q48509795 | ||
P2093 | author name string | Laura Ferrando-Climent | |
Ignasi Rodriguez-Roda | |||
Elissavet Kassotaki | |||
P2860 | cites work | Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance | Q29617864 |
Effects on activated sludge bacterial community exposed to sulfamethoxazole. | Q30637809 | ||
Antibacterial activity of sulfamethoxazole transformation products (TPs): general relevance for sulfonamide TPs modified at the para position | Q30850644 | ||
The link between nitrification and biotransformation of 17alpha-ethinylestradiol | Q31118700 | ||
Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies | Q33264630 | ||
Sorption and biodegradation of sulfonamide antibiotics by activated sludge: experimental assessment using batch data obtained under aerobic conditions | Q33885016 | ||
Polyclonal antibodies recognizing the AmoB protein of ammonia oxidizers of the beta-subclass of the class Proteobacteria | Q33988485 | ||
Evidence for the microbially mediated abiotic formation of reversible and non-reversible sulfamethoxazole transformation products during denitrification. | Q34156574 | ||
Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactor | Q35665264 | ||
Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review | Q37359484 | ||
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review | Q38009960 | ||
Biodegradation of sulfamethoxazole: current knowledge and perspectives | Q38035225 | ||
Insight into metabolic and cometabolic activities of autotrophic and heterotrophic microorganisms in the biodegradation of emerging trace organic contaminants | Q38129155 | ||
Pharmaceuticals as emerging contaminants and their removal from water. A review. | Q38136419 | ||
A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment | Q38176189 | ||
Ammonium removal by the oxygen-limited autotrophic nitrification-denitrification system | Q39563082 | ||
daime, a novel image analysis program for microbial ecology and biofilm research | Q39742703 | ||
Development of a common priority list of pharmaceuticals relevant for the water cycle | Q40009494 | ||
Aerobic biodegradation of the sulfonamide antibiotic sulfamethoxazole by activated sludge applied as co-substrate and sole carbon and nitrogen source | Q40106939 | ||
Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions | Q43118472 | ||
Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteria | Q43272931 | ||
The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. | Q43307525 | ||
Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. | Q43310489 | ||
Modelling cometabolic biotransformation of organic micropollutants in nitrifying reactors. | Q43322050 | ||
Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment | Q43323546 | ||
Occurrence of sulfonamide residues along the Ebro River basin: removal in wastewater treatment plants and environmental impact assessment. | Q43324602 | ||
Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions. | Q43326390 | ||
Removal of PPCPs from the sludge supernatant in a one stage nitritation/anammox process. | Q43326469 | ||
Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances | Q43337667 | ||
Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants. | Q43347942 | ||
Microbial degradation of pharmaceuticals in estuarine and coastal seawater | Q43366414 | ||
Biodegradation of natural and synthetic estrogens by nitrifying activated sludge and ammonia-oxidizing bacterium Nitrosomonas europaea. | Q44895677 | ||
Biodegradation and cometabolic modeling of selected beta blockers during ammonia oxidation. | Q46230005 | ||
Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters | Q46527216 | ||
Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden | Q46556967 | ||
On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole. | Q46557001 | ||
N2O and NO emissions from a partial nitrification sequencing batch reactor: exploring dynamics, sources and minimization mechanisms | Q48019619 | ||
Formation of diclofenac and sulfamethoxazole reversible transformation products in aquifer material under denitrifying conditions: batch experiments. | Q51375137 | ||
Understanding the removal mechanisms of PPCPs and the influence of main technological parameters in anaerobic UASB and aerobic CAS reactors. | Q53505572 | ||
Occurrence of drugs in German sewage treatment plants and rivers | Q56656254 | ||
Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment | Q57237725 | ||
Fate of sulfonamide antibiotics in contact with activated sludge – Sorption and biodegradation | Q59625582 | ||
Evaluation of the Persistence of Micropollutants Through Pure-Oxygen Activated Sludge Nitrification and Denitrification | Q59808963 | ||
Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme | Q60691289 | ||
Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant | Q84817863 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 111-119 | |
P577 | publication date | 2016-02-15 | |
P1433 | published in | Water Research | Q15708879 |
P1476 | title | Enhanced sulfamethoxazole degradation through ammonia oxidizing bacteria co-metabolism and fate of transformation products. | |
P478 | volume | 94 |
Q100514335 | A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes |
Q91161460 | Biotransformation of organic micropollutants by anaerobic sludge enzymes |
Q90127921 | Co-metabolism of sulfamethoxazole by a freshwater microalga Chlorella pyrenoidosa |
Q92273635 | Cometabolic biotransformation and microbial-mediated abiotic transformation of sulfonamides by three ammonia oxidizers |
Q99358306 | Concentration dependent degradation of pharmaceuticals in WWTP effluent by biofilm reactors |
Q47996470 | Degradation of emerging contaminants by acclimated activated sludge. |
Q50804529 | Degradation of sulfonamides as a microbial resistance mechanism. |
Q50196597 | Dye-sensitized TiO2-catalyzed photodegradation of sulfamethoxazole under blue or yellow light |
Q93346465 | Free nitrous acid (FNA) induced transformation of sulfamethoxazole in the enriched nitrifying culture |
Q43356814 | Impact of external carbon dose on the removal of micropollutants using methanol and ethanol in post-denitrifying Moving Bed Biofilm Reactors. |
Q41693314 | Microbial technology with major potentials for the urgent environmental needs of the next decades |
Q48031366 | Relative contribution of ammonia oxidizing bacteria and other members of nitrifying activated sludge communities to micropollutant biotransformation. |
Q103044722 | Study of free nitrous acid (FNA)-based elimination of sulfamethoxazole: Kinetics, transformation pathways, and toxicity assessment |
Q50905698 | Sulfamethoxazole degradation in anaerobic sulfate-reducing bacteria sludge system. |
Q89730075 | Unravelling kinetic and microbial responses of enriched nitrifying sludge under long-term exposure of cephalexin and sulfadiazine |
Search more.